SYNLAB UK & Ireland:

About Us

SYNLAB in the UK & Ireland

At SYNLAB, we provide laboratory, diagnostic and advisory services to a diverse range of sectors, including healthcare and wellness, sport, travel, insurance, veterinary and family law. We employ more than 2,800 people across the UK and Ireland and we carry out over 45 million tests each year.

We pride ourselves on the positive difference we make to people, animals, workplaces and other consumers by providing reliable, effective and timely diagnostic information. Our extensive network of laboratories offers thousands of different types of tests. These include routine blood, virology and toxicology, through to cutting edge molecular and genetic testing.

At SYNLAB, we are committed to advancing scientific and clinical practice through innovation, research and development. All our laboratories comply with industry standards and hold the accreditations relevant to their field of work. For laboratory-specific information, please see individual service pages.

We are proud to work with the NHS (National Health Service) through a number of hospital partnerships. These combine clinical excellence with the very best in innovation and transformation. SYNLAB’s involvement has enabled the NHS to realise a number of benefits, such as major improvements to patient services, access to state-of-the-art laboratories and diagnostic services, and better value for money.

SYNLAB UK & Ireland is part of SYNLAB Group, Europe’s leading medical diagnostic services provider. SYNLAB Group operates in 36 countries across four continents and carries out 500 million laboratory tests every year.

Video: Introducing SYNLAB Group
Latest SYNLAB UK & Ireland News
SYNLAB to Continue Providing COVID-19 Testing at UEFA Competition Matches and UEFA EURO 2020

10th June 2021 SYNLAB appointed by UEFA as ‘UEFA Laboratory Diagnostics Provider 2021/2022’ to be responsible for COVID-19 testing for players, officials and venue staff,…

Read More (about 'SYNLAB to Continue Providing COVID-19 Testing at UEFA Competition Matches and UEFA EURO 2020')
SYNLAB Goes Public 30th April 2021

We are proud to announce that SYNLAB is now listed on the Frankfurt Stock Exchange. This historical milestone is built on the dedication and passion…

Read More (about 'SYNLAB Goes Public 30th April 2021')
SYNLAB LABORATORY SERVICES 2020 ROUND UP

2020 was a challenging year for everyone. We’d like to thank all of our customers for their continued loyalty last year, we look forward to…

Read More (about 'SYNLAB LABORATORY SERVICES 2020 ROUND UP')
SYNLAB LABORATORY SERVICES 2020 ROUND UP

2020 was a challenging year for everyone. We’d like to thank all of our customers for their continued loyalty last year, we look forward to…

Read More (about 'SYNLAB LABORATORY SERVICES 2020 ROUND UP')
SYNLAB partners with Bristol Airport to provide first class Covid-19 testing service

15th December 2020 SYNLAB is teaming up with Bristol Airport to provide its customers with access to a high quality Covid-19 testing service which could…

Read More (about 'SYNLAB partners with Bristol Airport to provide first class Covid-19 testing service')
Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract

6th October 2020 We are delighted to announce that SYNLAB UK & Ireland will become the new pathology partner to Guy’s and St Thomas’ NHS…

Read More (about 'Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract')
Supporting UEFA to Restore European Football Competitions and Matches in a Safe Environment.

Delivering COVID-19 Testing Across All UEFA Competitions We are proud to be supporting UEFA, governing body of European football, with COVID-19 testing across all UEFA…

Read More (about 'Supporting UEFA to Restore European Football Competitions and Matches in a Safe Environment.')
SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing

13 July 2020 SYNLAB UK & Ireland and Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring…

Read More (about 'SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing')